source
- Cytiva podcast highlights decision confidence as key bottleneck in biopharma developmentIn a recent episode of the Denatured podcast, hosted by BioSpace Insights director Jennifer Smith-Parker, the conversation focused on the challenges facing biopharma companies. The guest, Nicolas P…
- FDA launches rare disease framework initiativeA new initiative from the US Food and Drug Administration (FDA) aims to develop “an optimized, fit-for-purpose” framework to facilitate the development and marketing of treatments for rare diseases…raps · 6d ago↗ source
- FDA expands Anktiva use for BCG-unresponsive high-grade papillary bladder cancer